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Approximately three million persons in the United States are 
infected with hepatitis C virus (HCV), a blood-borne pathogen 
that is an increasing cause of liver disease and mortality in the 
United States (1,2). Treatments for HCV are curative, of short 
duration, and have few associated side effects (3), increasing 
the importance of identifying HCV-infected persons. Many 
persons with HCV infection were infected decades ago, before 
implementation of prevention measures and most are unaware 
of their infection, regardless of when it occurred (4). Most 
newly diagnosed cases are associated with injection drug use 
(5). Persons born during 1945–1965 have a fivefold higher 
risk of HCV infection than other adults and the highest risk 
for HCV-related morbidity and mortality (6). CDC recom-
mends testing for this group, for persons who inject drugs, and 
others at risk for HCV infection (6,7). From October 2012 
through July 2014, the National Nursing Centers Consortium 
(NNCC) carried out a project to integrate routine HCV testing 
and linkage-to-care in five federally qualified health centers in 
Philadelphia, PA, that primarily serve homeless persons and 
public housing residents. During the project period, 4,514 
patients across the five centers were tested for HCV. Of these, 
595 (13.2%) were HCV-antibody positive and 550 (92.4%) 
had a confirmatory HCV-RNA test performed. Of those who 
had a confirmatory HCV-RNA test performed, 390 (70.9%) 
were identified as having current (i.e., chronic) HCV infection 
(overall prevalence = 8.6%). Of those currently infected with 
HCV, 90% were informed of their status, 78% were referred to 
an HCV care specialist, and 62% went to the referred specialist 
for care. Replicable system modifications that improved HCV 
testing and care included enhancements to electronic medical 
records (EMRs), simplification of HCV testing protocols, and 
addition of a linkage-to-care coordinator. Findings from this 
project highlight the need for innovative strategies for HCV 
testing, care, and treatment, as well as the important role of 
community health centers in expanding access for patient 
populations disproportionately affected by HCV infection (1).
In 2012, the NNCC, a national membership organization 
functioning to advance nurse-led care, partnered with its parent 
company, Public Health Management Corporation (PHMC)*, 
to implement routine HCV testing and referral to care in 
PHMC’s five federally qualified health centers (FQHCs) in 
Philadelphia, PA: 1) Mary Howard Health Center (exclusively 
serving homeless patients); 2) Rising Sun Health Center and 
3) PHMC Health Connection (both family medicine clinics 
serving public housing residents); 4) Congreso Health Center 
(serving primarily Hispanic patients); and 5) PHMC Care Clinic 
(offering primary care and specialized health services to patients 
with unmet medical and social needs, including treatment for 
patients with human immunodeficiency virus (HIV) and HCV 
infection). All of these health centers integrated routine HCV 
testing through a medical assistant-initiated, opt-out, laboratory-
based model with EMR modifications to prompt, track, report, 
and facilitate reimbursement for HCV tests.
Before testing began, the NNCC project manager and a 
local hepatitis C expert trained clinic personnel on HCV dis-
ease etiology, effects, and testing goals. The project manager 
assisted clinic staff with integrating testing into the existing 
clinic infrastructure to minimize disruption in routine services. 
Informational posters were placed in each health center to 
educate patients on prevalence, risk factors for HCV infection 
and recommendations for who should be tested. Patients eli-
gible for testing included those born during 1945–1965 (i.e., 
“Baby Boomers”), those with other risks for HCV infection 
(e.g., injection drug use) (6,7), and those who were homeless. 
An automatic electronic reminder, (the first of four EMR 
enhancements), identified patients eligible for testing based 
on birth year. Mary Howard Health Center and PHMC Care 
Clinic tested all patients, because most of those seen at these 
two clinics were assumed to be at increased risk for HCV infec-
tion. At the other three sites, medical assistants interviewed 
patients and tested those with at least one identified risk factor 
for HCV infection.
Medical assistants notified patients that they would be tested 
for HCV unless they opted out. For patients who verbally 
agreed to be tested, a standing order was in place to initiate the 
requisition for HCV-antibody with reflex to an HCV-RNA 
test to detect current HCV infection. With reflex testing, the 
laboratory uses the same specimen to perform an HCV-RNA 
test on any positive HCV-antibody test specimen, thus elimi-
nating the need for a second blood specimen to be collected 
from the patient. NNCC negotiated competitive pricing with 
commercial laboratories to perform HCV tests on uninsured 
* The Public Health Management Corporation (PHMC) is a nonprofit public 
health institute that builds healthier communities through partnerships with 
government, foundations, businesses and community-based organizations 
(additional information available at http://www.phmc.org/site/index.php).  
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patients and an account was created and added to the EMR 
(second EMR enhancement). Selecting this account generated 
a separate invoice specifically for HCV tests performed on 
uninsured patients.
Weekly reports showing the number of patients, by health 
center, who were tested and the names of those whose results 
were HCV-antibody-positive and HCV-RNA-positive were 
generated by the EMR (third EMR enhancement). These 
reports were sent to the project manager who provided the 
information to the clinic directors, medical assistants, and 
linkage-to-care coordinator. The latter assisted all patients 
who were HCV-antibody-positive through the care process, 
which included providing all current HCV-infected patients 
with their test results, offering onsite posttest counseling, 
and referring patients to HCV-care specialists (primary-care 
providers trained to care for patients infected with HCV, as 
well as hepatologists or gastroenterologists from one of the 
local academic medical centers) for medical evaluation. An 
automatic reminder was generated by the EMR (final EMR 
enhancement) alerting health-care providers that an HCV-
infected patient was eligible for linkage-to-care services, such 
as an escort to follow-up medical appointments, transporta-
tion reimbursements, reminder phone calls, and appointment 
scheduling. This report reflects data extracted from the EMR 
that was shared across all five health centers.
From October 1, 2012 through July 31, 2014, a total of 
4,514 patients were tested for HCV across the five FQHCs; 
595 (13.2%) had a positive HCV-antibody test result (Table). 
Among the HCV-antibody positive-patients, 550 (92.4%) 
had an HCV-RNA test performed and of these, 390 (70.9%) 
were identified with current HCV infection, for an overall 
prevalence of 8.6%. Most HCV-infected patients were male, 
non-Hispanic black, and had public insurance compared 
with others in these demographic subgroups. Although non-
Hispanic blacks accounted for a greater proportion of persons 
with current infection than non-Hispanic whites (53.6% versus 
29.5%), non-Hispanic whites had a greater overall prevalence 
of HCV infection compared with non-Hispanic blacks (21.1% 
versus 7.3%). Baby Boomers accounted for 62.6% of patients 
with current HCV infection. Among 352 patients reporting 
drug use, 205 (58.2%) reported having injected drugs in 
their lifetime. The two clinics conducting HCV testing for 
all patients, without ascertainment of risk (the PHMC Care 
Clinic and the Mary Howard Health Center), performed a 
greater number of tests compared with the other sites and had 
the highest proportion of patients who were HCV-antibody-
positive and currently infected. Of the 390 persons with cur-
rent HCV infection, 348 (89.2%) received their HCV-RNA 
positive results, 304 (78.0%) were referred to an HCV-care 
specialist for medical evaluation, and 240 (61.5%) were seen 
by the specialist (Figure). Of the 390 patients with current 
HCV infection, 25 (6.4%) began antiviral treatment during 
the data collection period of this project. The PHMC Care 
Clinic identified 247 HCV-infected patients and successfully 
linked 167 (67.6%) to medical care. Among the five FQHCs, 
the PHMC Care Clinic had the highest rates of linkage to care.
During the course of the project, HCV testing and care for 
patients at the FQHCs improved, as the result of a change 
in HCV-RNA test availability and additional system modi-
fications. In March 2013, all commercial laboratories began 
conducting reflex testing. Before this, testing for HCV-RNA 
was more cumbersome, requiring a second blood specimen be 
obtained at the same or at a subsequent visit. In the 5 months 
before reflex testing was routinely available, only 83.6% of 
the clinics’ patients with positive HCV antibody tests received 
confirmatory testing. From March through July 2013, early 
in the transition to reflex testing, this percentage increased to 
84.8%. However, by July 2014, as use of the reflex test became 
more routinely used, the percentage of HCV-antibody-positive 
patients who received confirmatory testing increased to 96.3%.
Another system modification initiated during the project was 
a change from provider-initiated testing to medical assistant-
initiated testing at the PHMC Care Clinic. At the beginning 
of the project, a nurse identified and reminded providers (with 
a chart note) of patients who were eligible for testing and the 
need to order an HCV test. An EMR prompt to identify Baby 
Boomers also was in place at this time. However, the process 
proved time intensive and inefficient: in clinics serving large 
patient populations with complex needs, chart notes were 
often overlooked and nurses had many other responsibilities. 
Medical assistant-initiated HCV testing resulted in a 6.3% 
increase in testing from an observation period of 11 months 
before compared with 11 months after implementing this 
procedural modification.
Beginning in September 2013, through funding from a 
public-private partnership, annual HIV testing for patients 
aged ≥13 years was implemented in the health centers, at which 
time the HCV testing protocol was modified to include HIV 
testing. Dual testing substantially increased the total number 
of HCV tests performed. A total of 1,786 HCV tests were 
performed during the 11-month project period leading up 
to this modification, whereas from September 2013 through 
July 2014, a total of 2,728 HCV tests were performed, repre-
senting a 52.7% increase.
A final modification that led to improved patient care was 
the addition of a linkage-to-care coordinator position. This 
coordinator was responsible for providing intensive services, 
including contacting patients who did not keep their appoint-
ments and addressing any barriers to care (e.g., affordable 
transportation). Between the 11 months before the addition 
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of the position and 11 months afterwards, these services 
increased the number of HCV-infected patients who received 
their positive HCV-RNA test results by 67.7% (from 130 to 
218 patients); patient referrals by 49.2% (from 122 to 182); 
and the number of patients seen by an HCV care specialist by 
28.6% (from 105 to 135).
Discussion
This project demonstrated that routine HCV testing can be 
successfully integrated into ambulatory care settings provid-
ing services for persons disproportionately affected by HCV 
infection. The project introduced six practices that could be 
replicated in other clinical settings. First, it tasked medical 
assistants with guiding patients through the HCV testing 
process, relieving the burden on clinicians and other health 
center staff. Second, reflex HCV testing technology was used 
to ensure that HCV-antibody positive patients received HCV-
RNA testing necessary to detect current HCV infection. Such 
testing also allowed patients to receive test results and care 
referrals in one visit. Third, test costs associated with patients 
without insurance were eliminated as a barrier to testing. 
Fourth, modifying the HCV testing protocol to include HIV 
testing led to substantial increases in the number of HCV tests 
performed and currently infected patients identified (82.6% 
increase). Because more patients were eligible for HIV testing, 
the HCV test was easily added to the laboratory requisition.
Fifth, EMR modifications also improved patient care. The 
EMR prompted testing and the need for linkage-to-care ser-
vices, all of which were monitored by the project manager and 
the linkage-to-care coordinator. Weekly reports tracked testing 
and patient progression through the HCV care continuum. 
EMR modifications also simplified the payment process for 
HCV tests performed on uninsured patients. Finally, intensive 
services carried out by the linkage-to-care coordinator increased 
the number of currently infected patients who received their 
results and were referred and seen by a specialist. This effort 
ensured that more patients received appropriate posttest 
counseling and medical evaluation for liver health and HCV 
treatment initiation.
TABLE. Number, percentage, and prevalence of patients tested for HCV, and identified as HCV-antibody positive and currently infected*, by 
demographic characteristics and health centers† — Philadelphia PA, October 2012–July 2014
Characteristic
HCV-Antibody Tested HCV-Antibody Positive Currently Infected§
No. (%) No. (%)¶ Prevalence** (%) No. (%)†† Prevalence§§ (%)
Sex
Male 2,522 (55.9) 421 (70.8) (16.7) 297 (76.2) (11.8)
Female 1,992 (44.1) 174 (29.2) (8.7) 93 (23.8) (4.7)
Race/Ethnicity
Non-Hispanic Black 2,862 (63.4) 309 (51.9) (10.8) 209 (53.6) (7.3)
Non-Hispanic White 545 (12.1) 173 (29.1) (31.7) 115 (29.5) (21.1)
Hispanic 724 (16.0) 81 (13.6) (11.2) 48 (12.3) (6.6)
Asian 136 (3.0) 5 (0.8) (3.7) 5 (1.3) (3.7)
Other 77 (1.7) 2 (0.3) (2.6) 1 (0.3) (1.3)
Missing 170 (3.8) 25 (4.2) (14.7) 12 (3.1) (7.1)
Birth Year Cohort
<1945 53 (1.2) 2 (0.3) (3.8) 2 (0.5) (3.8)
1945–1965 1,890 (41.9) 366 (61.5) (19.4) 244 (62.6) (12.9)
>1965 2,571 (57.0) 227 (38.2) (8.8) 144 (36.9) (5.6)
Health Insurance Type
Uninsured 1,495 (33.1) 126 (21.2) (8.4) 77 (19.7) (5.2)
Public Insurance 2,704 (59.9) 433 (72.8) (16.0) 290 (74.4) (10.7)
Private Insurance 315 (7.0) 36 (6.1) (11.4) 23 (5.9) (7.3)
Health Center
Care Clinic 1,518 (33.6) 358 (60.2) (23.6) 247 (63.3) (16.3)
Mary Howard 1,079 (23.9) 159 (26.7) (14.7) 108 (27.7) (10.0)
PHMC Health
Connection
837 (18.5) 31 (5.2) (3.7) 11 (2.8) (1.3)
Rising Sun 808 (17.9) 24 (4.0) (3.0) 12 (3.1) (1.5)
Congreso 272 (6.0) 23 (3.9) (8.5) 12 (3.1) (4.4)
Total 4,514 (100) 595 (100) (13.2) 390 (100) (8.6)
Abbreviation: HCV = hepatitis C virus
 * Currently infected indicates a diagnosis of chronic infection with HCV based on positive results of HCV-RNA testing.
 † Health centers are five federally qualified health centers owned and managed by the Public Health Management Corporation, Philadelphia, PA.
 § 550 (92.4%) of 595 persons with HCV-antibody positive tests received HCV-RNA testing.
 ¶ Percent positive among those tested.
 ** Percent positive among those tested in each demographic subgroup and health center.
 †† Percent currently infected among those tested.
 §§ Percent currently infected among those tested in each demographic subgroup.  
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The project successfully targeted patients at high risk for 
HCV infection; overall 8.6% of patients were infected with 
HCV, a higher proportion than previous estimates. Only 1% 
(0.8%–1.2%) of the general U.S. population is estimated to be 
infected with HCV (1). A geographically targeted community-
based testing program also carried out in Philadelphia found 
that 2.8% of persons were estimated to be living with current 
HCV infection (8). The percentage of patients receiving an 
HCV-RNA test confirming their current infection status 
likewise was higher (92% versus 47%) than that reported by 
the Philadelphia Department of Public Health from routine 
surveillance of viral hepatitis (9). The higher percentage in this 
project is largely attributable to the use of reflex testing (10), 
which ensures that a greater number of persons are tested for 
current infection and can learn their infection status without 
returning to provide a second blood specimen.
A relatively small proportion of HCV-antibody-positive 
patients (7.6%) did not receive a confirmatory test during the 
project period. There are several possible reasons for this. Some 
patients submitted specimens early in the project, before the 
implementation of reflex testing, and might not have returned 
for confirmatory HCV-RNA test. Specimens submitted for 
confirmatory testing might not have met 
laboratory testing requirements because of 
insufficient quantity or improper handling. 
Providers might have inadvertently ordered the 
hepatitis panel that currently only includes an 
HCV-antibody test.
Linkage-to-care rates also were higher than 
those observed in Philadelphia surveillance 
data (9), an outcome likely attributed to 
creation of the linkage-to-care coordinator 
position. Initially, linkage services included 
reminder phone calls, public transportation 
tokens for patients to attend appointments, 
or patient escorts. However, some patients 
were found to require additional services. The 
linkage-to-care coordinator provided intensive 
support services: following up with patients 
who did not keep appointments; conduct-
ing off-site (e.g., home, shelters, and halfway 
houses) visits as necessary; acting as an interme-
diary point of contact between the patient and 
the FQHCs; and helping identify and resolve 
any barriers patients experienced in attending 
appointments. These services fostered trusting 
relationships with patients. Additionally, the 
linkage-to-care coordinator remained a point 
of contact for HCV-infected patients that had 
fallen out of care because of addiction, unstable housing, or 
distrust of health care systems. The linkage-to-care coordinator 
worked with these patients until they were ready to reengage 
in care, linked them to social and addiction support programs, 
and provided specialized care plans to ensure they attended 
their HCV medical appointments. Similar intensive linkage 
services in community-based HCV testing and linkage-to-
care programs in Philadelphia also have proven successful in 
navigating HCV-infected patients into care (8).
The most successful linkage-to-care rates were seen at the 
PHMC Care Clinic, where HCV testing, care, and treatment 
are provided in the same setting. This test-and-treat model 
eliminates the need to refer patients to an outside care pro-
vider, except in extenuating circumstances (e.g., a patient with 
advanced liver disease or cirrhosis). Because of the high number 
of HCV-infected patients seen there, the Mary Howard Health 
Center plans to expand its services to include on-site HCV treat-
ment. Linkage-to-care rates were lowest at health centers serving 
patients at low risk of HCV infection. Because they served fewer 
HCV-infected patients, providers at these sites might not be as 
aware of the HCV linkage-to-care protocol. To increase rates in 
these settings, HCV protocols will be updated and included in 
an automated centralized forum accessible by staff for training.
FIGURE. Contiuum of care process for patients with chronic hepatitis C (HCV) infection* 
treated at five federally qualified health centers (FQHCs)† — Philadelphia, PA, October 
2012–July 2014
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Abbreviation: RNA+ = Patients whose specimens tested positive for HCV. 
 * Patients with chronic HCV infection are defined as those who are currently infected with HCV based 
upon a positive result to HCV-RNA test.
 † All five FQHCs are owned and managed by Philadelphia-based Public Health Management Corporation.
 § Error bars are the range of percentages for each stage of care across all five FQHCs.
 ¶ Average = average of values at all five FQHCs.
 ** Specialists include primary care providers who were trained to care for patients infected with HCV, 
as well as hepatologists or gastroenterologists from one of the local academic medical centers.  
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There were two main limitations of this project. The first was 
its relatively small size. HCV testing and linkage to care were 
integrated into a small network of health centers and therefore 
the practices and lessons learned from the project may not be 
applicable to larger settings, such as a large hospital system, or 
in other geographic areas. To address this, NNCC is exploring 
ways to replicate this model in larger health center networks 
in other cities. Second, the duration of the project did not 
follow patients through HCV treatment to cure. NNCC is 
working with offices of local HCV providers to collect data 
on treatment history and clinical outcomes.
The high rate of HCV infection among persons in dis-
proportionately affected populations, like those seen at the 
five FQHCs, indicates a need for innovative models that can 
identify persons with HCV infection and ensure they receive 
appropriate care. Delivering care via trusted health care profes-
sionals at primary care settings can improve outcomes at every 
stage of the continuum of care, from reflex testing to providing 
timely test results and linking patients to HCV-focused care. 
In collaboration with public health agencies and other service 
providers, community health centers are optimally positioned 
to play an important role in expanding access to recommended 
HCV testing, care, and treatment for populations dispropor-
tionately affected by hepatitis C.
 1National Nursing Centers Consortium; 2Philadelphia Department of Public 
Health; 3Division of Viral Hepatitis, CDC
Corresponding author: Catelyn R. Coyle, ccoyle@nncc.us, 215-825-8278
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What is already known about this topic?
Hepatitis C virus (HCV) infection is a major cause of chronic liver 
disease and hepatocellular carcinoma and the leading indication 
for liver transplantation in the United States. Approximately three 
million persons in the United States are infected with HCV, and 
many are unaware of their status and are diagnosed late. As 
persons disproportionately affected by HCV (e.g., poor, homeless, 
born during 1945-1965, injection drug users) age, HCV-related 
morbidity, mortality, and spending are expected to increase.
What is added by this report?
Routine HCV testing and linkage-to-care for persons with 
current infection were successfully integrated into five federally 
qualified health centers in Philadelphia, PA. Across the centers, 
595 (13.2%) of 4,514 patients tested were HCV-antibody positive 
and 550 (92.4%) received HCV-RNA testing. Of the 390 (70.9%) 
with current (chronic) HCV infection, 348 (89.2%) received their 
results, 304 (78.0%) were referred to and 240 (61.5%) were seen 
by a provider familiar with HCV care and treatment. This project 
demonstrated the feasibility of identifying low-income persons 
living with HCV infection and linking them to care.
What are the implications for public health practice?
In collaboration with public health agencies and other service 
providers, community health centers are optimally positioned 
to play a pivotal role in expanding access to recommended HCV 
testing, care, and treatment for populations disproportionately 
affected by hepatitis C. Delivering HCV-related care via trusted 
healthcare professionals, with the addition of embedded and 
intensive support services, at primary care settings can increase 
successful outcomes at every stage of the care continuum.
